Dr. Solomon J Sager, M.D. Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 804 E Woodfield Rd, Suite 300, Schaumburg, IL 60173 Phone: 847-605-9500 Fax: 847-637-0737 |
Muhammad Adnan Balouch, Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 804 E Woodfield Rd, Schaumburg, IL 60173 Phone: 847-605-0030 Fax: 847-637-0737 |
Parag M Doshi, M.D. Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 804 Woodfield Rd, Suite 300, Schaumburg, IL 60173 Phone: 847-605-9500 Fax: 847-605-8700 |
Yeong H. Kim, M.D. Internal Medicine - Cardiovascular Disease Medicare: Not Enrolled in Medicare Practice Location: 455 S Roselle Rd, #207, Schaumburg, IL 60193 Phone: 847-301-1212 Fax: 847-301-1277 |
John Kevin O'donoghue, M.D. Internal Medicine - Cardiovascular Disease Medicare: Not Enrolled in Medicare Practice Location: 804 E Woodfield Rd, Suite 300, Schaumburg, IL 60173 Phone: 847-605-9500 Fax: 847-605-8700 |
News Archive
New research on autism in adults has shown that adults with a more severe learning disability have a greater likelihood of having autism.
When Grace Jividen competed in the 1992 Olympics in Barcelona, Spain, she couldn't hear her opponent's breathing, which she believes could have given her the edge in her judo competitions. Now, the former member of the 1992 U.S. women's judo team and holder of more than 41 medals from international competitions and a sixth degree black belt has the edge she was looking for thanks to Lyric, the world's first 100 percent invisible extended wear hearing device.
Back and neck pain sufferers who divide the most frequently prescribed muscle relaxant may be getting anywhere from half to one-and-a-half times the amount of medicine they believe they are taking, suggests a new study examining the practice of tablet splitting.
WHO alerts countries to the increasing trend of resistance to HIV drugs detailed in a report based on national surveys conducted in several countries.
Nearly one in four patients with chronic hepatitis C (HCV) are denied initial approval for a drug therapy that treats the most common strain of the infection, according to a Yale School of Medicine study.
› Verified 2 days ago